as on
| Source : BSE
as on August 19, 2025 at 4:01 PM IST
52 Week's Low
52 Week's High
14.11%
Downside
44.72%
Upside
Market Stats | |
Previous Close | ₹18.00 |
Open | ₹18.00 |
Volume | 100.00 |
Upper Circuit | ₹18.90 |
Lower Circuit | ₹17.10 |
Day's Low | ₹18 |
Day's High | ₹18 |
52 Week Low | ₹15.46 |
52 Week High | ₹26.05 |
Returns % | |
1 Month Return | + 1.58 % |
3 Month Return | + 0.95 % |
1 Year Return | -2.65 % |
3 Year Return | + 3.87 % |
5 Year Return | -36.62 % |
Check Brawn Biotech Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹5.40 Cr
Return on Equity (ROE)
0PE Ratio (TTM)
0Return on capital employed (ROCE)
0Beta (LTM)
-0.09
P/B Ratio
1.18
Dividend Yield
0PEG Ratio
0Quarterly Earnings Growth YOY
0EPS (TTM)
0Sector
Pharmaceuticals
Book Value
0Technical Analysis
Bearish
View Technical Analysis
Get the annual and quarterly financial summary of Brawn Biotech Ltd, including revenue, profit, loss and more.
View detailed summary of the earnings and dividend history of Brawn Biotech Ltd.
Brawn Biotech Ltd’s net profit fell -300% since last year same period to ₹0.04Cr in the Q1 2023-2024. On a quarterly growth basis, Brawn Biotech Ltd has generated -117.39% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2018, Brawn Biotech Ltd has declared dividend of ₹1.00 per share on 29 May 2018 - translating a dividend yield of 13.89%.
Read More about DividendsView the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Brawn Biotech Ltd.
Investors | Holdings % | Quarterly Trend | 3M change |
---|---|---|---|
Promoter Holdings | 53.66% | 0.00 | |
Foreign Institutions | 0% | 0.00 | |
Mutual Funds | 0.35% | 0.00 | |
Retail Investors | 45.99% | 0.00 | |
Others | 0% | 0.00 |
Compare market cap, revenue, PE, and other key metrics of Brawn Biotech Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
---|---|---|---|---|---|---|
NA | 5.40 | -7.32% | 0.00 | -2 | 16 | |
NA | 738.47 | 32.13% | 0.51 | 421 | 1,280 | |
NA | 20.25 | 6.48% | 0.00 | NA | 58 | |
NA | 88.03 | -2.89% | 0.00 | 3 | 53 | |
BUY | 26,821.04 | 66.05% | 0.51 | 659 | 3,917 |
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 7 days, Brawn Biotech stock has moved up by 8.0%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 53.66% of holdings in Jun 2025 quarter
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 32.0% return, outperforming this stock by 34.7%
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 136.7% return, outperforming this stock by 132.8%
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 45.99% of holdings in Jun 2025 quarter
Organisation | Brawn Biotech Ltd |
Headquarters | New Delhi |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Brawn Biotech Ltd share price today stands at ₹18, Open: ₹18, Previous Close: ₹18, High: ₹18, Low: ₹18, 52 Week High: ₹26.05, 52 Week Low: ₹15.46 as on .
To buy Brawn Biotech Ltd shares, you need to follow these steps:
Today's traded volume of Brawn Biotech Ltd is 100.00. Which means that 100.00 shares of Brawn Biotech Ltd were bought and sold on the stock market during today's trading session.
Today's market capitalisation of Brawn Biotech Ltd is ₹5.40 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
Brawn Biotech Ltd’s 52 week high is ₹26.05 and 52 week low is ₹15.46. The current share price of Brawn Biotech Ltd is ₹18, which is -30.90% down from its 52 week high and 16.43% up from its 52 week low.